Biodegradable Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026

 

Stents are metal scaffolding used to unblock a blocked channel and improve the passage of biliary fluid or blood through it. Biodegradable stents, also known as bioresorbable stents, are a type of stent manufactured from unique biodegradable materials such as polymers and metal, which eliminates the need for stent removal and the adverse effects associated with traditional stents. Polylactic acid (PLA), poly-DL-lactic acid (PDLLA), poly-L-lactic acid (PLLA), poly-DL-lactide-co-glycolide (PDLGA), poly-lactic-co glycolide (PLGA), polycaprolactone (PCL), and polylactic acid/polycaprolactone (PLA/PCL) are biodegradable polymers evaluated for stent manufacture, whereas magnesium, stainless steel, and cobalt chro In the presence of water, biodegradable materials hydrolyze and transform into simple biological components.

A stent is a medical device that is put into the body's internal duct to enlarge blood arteries and prevent them from being blocked. Bioabsorbable stents, also known as Biodegradable Stents Market or naturally-dissolving stents, are constructed of materials that are absorbed by the body and act to relieve the obstruction produced by plaque deposits by widening the veins or internal ducts. These devices are engineered in such a way that the stents dissolve within the body after the medicine has been eluted.

The rise in geriatric population, rise in cardiovascular disease prevalence, surge in percutaneous coronary intervention (PCI) procedures, and rise in bioabsorbable stent adaptation by patients and physicians are the important drivers driving the growth of the worldwide Biodegradable Stents Market. Furthermore, advancements in stent technology, increased demand for minimally invasive operations, and increased government effort for the research and production of Biodegradable Stents Market drive market expansion. According to the Centers for Disease Control and Prevention (CDC), the global prevalence of coronary heart condition in 2017 was over 18.2 million people, with approximately 2 in 10 persons dying from the disease.